fda banned bpc 157 BPC-157 Approval Status: Is It Approved for Human Use? Exclusive: As the Trump administration
Description
doi: 10.1172/JCI84877
In Graves disease, where extrathyroidal manifestations are mediated by TSHR/IGF-1R-expressing fibroblasts, studies could test GLP-1RAs as adjuncts to antithyroid drugs or biologics (for example, alongside IGF-1R blockade for orbitopathy) to reduce systemic inflammation and metabolic drivers without compromising disease control [19,25,67]
That finding alone makes it worth considering for anyone struggling with GI-related side effects
[DOI] [PMC free article] [PubMed] [Google Scholar] 34.Davis EC, Dinsmoor AM, Wang M, et al
This published research has shown significant promise of BPC 157 promoting wound healing and tissue repair
Arnold F
